Our vision is to become a leading pharmaceutical company focusing on three core therapeutic areas, namely anti-infectives, cardiovascular disease (‘CVD') and respiratory system, by leveraging our full value chain capabilities.
We believe our drug asset sourcing track record, advanced manufacturing facility, international supply chain management capabilities and MNC-caliber senior management team, together with our in-depth local market insights, scaled local commercial platform, localized manufacturing facilities and local operating track record, position us well to further strengthen our competitive advantages in the pharmaceutical industry in China.